| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/08/1995 | CA2177252A1 Human mutator gene hmsh2 and hereditary non polyposis colorectal cancer |
| 06/08/1995 | CA2177031A1 Inhibition of dna methyltransferase |
| 06/08/1995 | CA2174972A1 Binding structures directed against the ca55.1 antigen |
| 06/07/1995 | EP0656360A1 Trifluoromethylpyrroloindole carboxylic ester derivative and process for producing the same |
| 06/07/1995 | EP0656213A1 Treatment of conditions and disease |
| 06/07/1995 | EP0656211A1 Stable lyophilized thiotepa composition |
| 06/07/1995 | EP0656208A2 Use of synthetic huminates for the manufacture of a medicament for the treatment of disease of the mucosa |
| 06/07/1995 | EP0656115A1 Improved detection and therapy of lesions with biotin/avidin conjugates |
| 06/07/1995 | EP0656069A1 Inhibitors of cell proliferation, their preparation and use |
| 06/07/1995 | EP0655926A1 New tumor diagnosing or therapeutical probe |
| 06/07/1995 | EP0655925A1 Anti-cancer therapeutic compositions containing whey protein concentrate |
| 06/07/1995 | EP0655924A1 A COMBINATION OF ANTI-erbB-2 MONOCLONAL ANTIBODIES AND METHOD OF USING |
| 06/07/1995 | EP0655923A1 Antiangiogenic oligomers |
| 06/07/1995 | EP0655920A1 Astragalus polysaccharide immunomodulators |
| 06/07/1995 | EP0655918A1 Treatment of cancer with azt and alkylating or intercalating agents |
| 06/07/1995 | EP0655913A1 Novel metallocenes as anti-tumor drugs |
| 06/07/1995 | EP0454783B1 Site specific in-vivo activation of therapeutic drugs |
| 06/07/1995 | CN1103533A Biologically active ureido derivatives useful as antimetastatic agents |
| 06/07/1995 | CN1103431A Determination of lymph nodes enriched in tumor reactive... |
| 06/07/1995 | CN1103402A Substituted pyrroles |
| 06/07/1995 | CN1103401A Production of pyrrolopyrimidines and intermadiates therefor |
| 06/06/1995 | US5422371 Contacting a cell with a fatty acid or fatty alcohol to prevent reduction of testosterone to 5a-dihydrotestosterone |
| 06/06/1995 | US5422359 α-aminoketone derivatives |
| 06/06/1995 | US5422104 TNF-muteins |
| 06/06/1995 | CA1335800C Synovial phospholipases |
| 06/01/1995 | WO1995014777A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME |
| 06/01/1995 | WO1995014714A1 Novel integrin-binding peptides |
| 06/01/1995 | WO1995014706A1 Pna-dna-pna chimeric macromolecules |
| 06/01/1995 | WO1995014697A1 Heterocyclic esters of rapamycin and pharmaceutical compositions containing them |
| 06/01/1995 | WO1995014696A1 Hindered esters of rapamycin and their use as pharmaceuticals |
| 06/01/1995 | WO1995014683A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 06/01/1995 | WO1995014493A1 Three-step pretargeting methods and compounds |
| 06/01/1995 | WO1995014459A1 Liposomes for the encapsulation of doxorubicine |
| 06/01/1995 | CA2177074A1 P53-binding polypeptides and polynucleotides encoding same |
| 06/01/1995 | CA2177070A1 Novel integrin-binding peptides |
| 06/01/1995 | CA2177037A1 Three-step pretargeting methods and compounds |
| 06/01/1995 | CA2176961A1 Heterocyclic esters of rapamycin and pharmaceutical compositions containing them |
| 06/01/1995 | CA2176955A1 Hindered esters of rapamycin and their use as pharmaceuticals |
| 06/01/1995 | CA2174838A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 05/31/1995 | EP0655462A1 Linear adhesion inhibitors |
| 05/31/1995 | EP0655460A1 Pharmacotherapeutical use of glutathione derivatives |
| 05/31/1995 | EP0655455A1 Novel phosporus containing pyridine derivatives |
| 05/31/1995 | EP0655239A1 Liposomes encapsulating doxorubicine |
| 05/31/1995 | EP0655066A1 Protein kinase inhibitors and related compounds combined with taxol |
| 05/31/1995 | EP0655060A1 Pharmaceutically active diketopiperazines |
| 05/31/1995 | EP0655055A1 Tachykinin antagonists |
| 05/31/1995 | EP0654993A1 Method for destroying or inhibiting growth of unwanted cells or tissues |
| 05/31/1995 | EP0654973A1 System of drug delivery to the lymphatic tissues |
| 05/31/1995 | EP0574433B1 6,9-BIS(AMINO SUBSTITUTED)BENZO g]PHTHALAZINE-5,10-DIONES AS ANTITUMOR AGENTS |
| 05/31/1995 | EP0553281B1 Preparation and characterization of liposomal formulations of tumor necrosis factor |
| 05/30/1995 | US5420319 Cis-oxalato(trans-1-1,2-cyclohexanediamine) Pt(II) complex having high optical purity and process of preparing same |
| 05/30/1995 | US5420296 Angiogenesis inhibitors and cardiovascular disorders |
| 05/30/1995 | US5420273 Condensed heterocyclic compounds |
| 05/30/1995 | US5420247 Genetic engineering and expression vectors |
| 05/30/1995 | US5420157 Anticancer agents |
| 05/30/1995 | US5420149 Imidazolyl-substituted phenylacetamides |
| 05/30/1995 | US5419904 Human B-lymphoblastoid cell line secreting anti-ganglioside antibody |
| 05/30/1995 | US5419899 Purified, reduced recombinant interleukin-2 compositions |
| 05/30/1995 | CA1335717C Human granulocyte-macrophage colony stimulating factor and muteins thereof |
| 05/26/1995 | WO1995014101A1 Recombinant adenoviruses for gene therapy in cancers |
| 05/26/1995 | WO1995014100A2 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting |
| 05/26/1995 | WO1995014085A2 A method for detection of alterations in the dna mismatch repair pathway |
| 05/26/1995 | WO1995014080A1 Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor |
| 05/26/1995 | WO1995014026A1 Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use |
| 05/26/1995 | WO1995014022A1 NEW PIRROLO [3,2-e]INDOL DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS |
| 05/26/1995 | WO1995014008A1 Substituted 5-ring heterocycles, their preparation and their use |
| 05/26/1995 | WO1995013830A1 Method for inhibiting angiogenesis using heparinase |
| 05/26/1995 | WO1995013820A1 Use of an agent which modulates tyrosine phosphorylation for modulating the permeability of a psychological barrier |
| 05/26/1995 | WO1995013801A1 Fatty acid delivery system |
| 05/26/1995 | WO1995013798A1 Controlled release preparation |
| 05/26/1995 | WO1995013701A1 Novel fas protein and methods of use thereof |
| 05/26/1995 | WO1995011977A3 A NEW RIBOSOME-INACTIVATING PROTEIN ISOLATED FROM THE PLANT $i(BRYONIA DIOICA) |
| 05/26/1995 | WO1994027584A3 Arylating medicaments |
| 05/26/1995 | CA2176934A1 Method for inhibiting angiogenesis using heparinase |
| 05/26/1995 | CA2176933A1 Controlled release preparation |
| 05/26/1995 | CA2176819A1 A method for detection of alterations in the dna mismatch repair pathway |
| 05/26/1995 | CA2176585A1 Recombinant adenoviruses for gene therapy in cancers |
| 05/26/1995 | CA2176575A1 Novel fas protein and methods of use thereof |
| 05/26/1995 | CA2176014A1 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting |
| 05/26/1995 | CA2169643A1 Substituted 5-ring heterocycles, their preparation and their use |
| 05/24/1995 | EP0654467A2 Vitamin D3 analogs |
| 05/24/1995 | EP0654269A1 Medicinal composition for inhibiting cancer metastasis to liver and medicinal composition for curing hepatoma |
| 05/24/1995 | EP0654268A1 A method to reverse the phenotype of transformed cells by the transcription factor IRF-1 |
| 05/24/1995 | EP0654265A1 Aromatase-inhibiting composition containing azole derivative |
| 05/24/1995 | EP0654084A1 Molecular cloning of the genes reponsible for collagenase production from clostridium histolyticum |
| 05/24/1995 | EP0654083A1 Ptp-d subfamily of protein tyrosine phosphatases |
| 05/24/1995 | EP0654024A1 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties |
| 05/24/1995 | EP0653942A1 Morphogen-induced nerve regeneration and repair |
| 05/24/1995 | EP0653940A1 Glial mitogenic factors, their preparation and use |
| 05/24/1995 | EP0574394B1 Substances of polypeptide nature useful in human therapy |
| 05/24/1995 | EP0520029B1 Methods and compositions for the treatment of malignancies in which a protein kinase is associated |
| 05/24/1995 | EP0357767B1 Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates |
| 05/24/1995 | CN1028542C Anticancer antibiotic MZ43-37F11 substance, the production and uses thereof |
| 05/24/1995 | CA2135587A1 Antitumor antibiotics |
| 05/23/1995 | US5418233 For inhibiting cell aggregation |
| 05/23/1995 | US5418157 Recombinant 68,000 dalton collagenase of Clostridium histolyticum |
| 05/23/1995 | US5417978 Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use |
| 05/23/1995 | CA1335686C Vinblastin and pharmaceutical composition comprising them |
| 05/19/1995 | CA2118443A1 Aromatase-inhibiting composition containing azole derivative |
| 05/18/1995 | WO1995013385A2 Thrombin mutants |